SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001213900-20-003270
Filing Date
2020-02-11
Accepted
2020-02-11 11:46:37
Documents
2
Group Members
REGALS CAPITAL MANAGEMENT LPREGALS FUND LP

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sc13g1219david_oramedpharm.htm SC 13G 86562
2 AGREEMENT OF JOINT FILING sc13g1219ex99-1david_oramed.htm EX-99.1 4163
  Complete submission text file 0001213900-20-003270.txt   92275
Mailing Address 1185 AVENUE OF THE AMERICAS, SUITE 228 NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, SUITE 228 NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Subject) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 0831
Type: SC 13G | Act: 34 | File No.: 005-79895 | Film No.: 20595138
SIC: 2834 Pharmaceutical Preparations

Mailing Address 152 WEST 57TH STREET, 9TH FLOOR NEW YORK NY 10019
Business Address
Slager David Mark (Filed by) CIK: 0001477733 (see all company filings)

Type: SC 13G